Total Payments
$1,233
2024 Payments
$265.09
Companies
23
Transactions
76
Medicare Patients
3,513
Medicare Billing
$289,464
Payment Breakdown by Category
Food & Beverage$1,233 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,233 | 76 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $199.55 | 14 | $0 (2024) |
| Novo Nordisk Inc | $100.16 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $99.45 | 1 | $0 (2017) |
| Amgen Inc. | $93.10 | 6 | $0 (2023) |
| AbbVie Inc. | $88.68 | 6 | $0 (2023) |
| Lilly USA, LLC | $83.69 | 6 | $0 (2023) |
| Abbott Laboratories | $69.87 | 4 | $0 (2024) |
| Genentech USA, Inc. | $59.34 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $54.68 | 4 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $52.35 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $265.09 | 14 | Genentech USA, Inc. ($59.34) |
| 2023 | $386.91 | 25 | Amgen Inc. ($93.10) |
| 2022 | $314.35 | 23 | AstraZeneca Pharmaceuticals LP ($54.68) |
| 2021 | $28.09 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28.09) |
| 2020 | $23.82 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12.33) |
| 2019 | $51.15 | 4 | SANOFI-AVENTIS U.S. LLC ($25.45) |
| 2018 | $36.32 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($25.33) |
| 2017 | $127.06 | 3 | E.R. Squibb & Sons, L.L.C. ($99.45) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: DIABETES | ||||||
| 08/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $59.34 | General |
| Category: Immunology | ||||||
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: DIABETES | ||||||
| 06/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes Care | ||||||
| 05/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: VACCINES | ||||||
| 04/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Cardio-renal | ||||||
| 03/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: VACCINE | ||||||
| 02/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes Care | ||||||
| 02/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Insomnia | ||||||
| 12/15/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Diabetes Care | ||||||
| 12/07/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Inflammation | ||||||
| 12/05/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Inflammation | ||||||
| 10/26/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.39 | General |
| 10/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: INSOMNIA | ||||||
| 10/04/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: WOMENS HEALTH | ||||||
| 08/31/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Inflammation | ||||||
| 08/10/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 07/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.61 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 848 | 1,123 | $475,087 | $65,690 |
| 2022 | 12 | 773 | 998 | $384,554 | $74,366 |
| 2021 | 13 | 1,050 | 1,398 | $180,252 | $86,525 |
| 2020 | 14 | 842 | 1,146 | $153,745 | $62,883 |
Total Patients
3,513
Total Services
4,665
Medicare Billing
$289,464
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 367 | $206,606 | $21,681 | 10.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 151 | 151 | $86,681 | $10,955 | 12.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $40,860 | $9,877 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 195 | $78,010 | $9,461 | 12.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 63 | $17,640 | $4,532 | 25.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 75 | 76 | $7,996 | $2,582 | 32.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 33 | $13,218 | $2,138 | 16.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $10,300 | $1,364 | 13.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 38 | 38 | $3,914 | $1,291 | 33.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 76 | 78 | $5,197 | $782.00 | 15.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 12 | $2,814 | $555.84 | 19.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $1,131 | $282.27 | 25.0% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 35 | 36 | $576.00 | $149.40 | 25.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 12 | $144.00 | $40.92 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 293 | $160,730 | $26,490 | 16.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 127 | 127 | $71,111 | $18,523 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 210 | $82,554 | $13,792 | 16.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 66 | $16,104 | $4,524 | 28.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 74 | 74 | $7,622 | $2,493 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 15 | $11,850 | $2,170 | 18.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 29 | 32 | $12,019 | $2,131 | 17.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 13 | $7,306 | $1,481 | 20.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 91 | 96 | $6,036 | $1,048 | 17.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $6,902 | $1,002 | 14.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $1,648 | $541.12 | 32.8% |
About Dr. Cherryl Thomas, MD
Dr. Cherryl Thomas, MD is a Specialist healthcare provider based in Monroe Twp, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134113640.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cherryl Thomas, MD has received a total of $1,233 in payments from pharmaceutical and medical device companies, with $265.09 received in 2024. These payments were reported across 76 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,233).
As a Medicare-enrolled provider, Thomas has provided services to 3,513 Medicare beneficiaries, totaling 4,665 services with total Medicare billing of $289,464. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Monroe Twp, NJ
- Active Since 09/12/2005
- Last Updated 01/04/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1134113640
Products in Payments
- JARDIANCE (Drug) $167.49
- ELIQUIS (Drug) $99.45
- Otezla (Drug) $93.10
- CAPLYTA (Drug) $83.40
- Xolair (Biological) $59.34
- QULIPTA (Drug) $58.28
- FREESTYLE LIBRE 3 (Device) $55.36
- FARXIGA (Drug) $54.68
- NURTEC ODT (Drug) $52.35
- TRULICITY (Drug) $40.56
- QUVIVIQ (Drug) $30.85
- UBRELVY (Drug) $30.40
- Adzenys XR-ODT (Drug) $27.74
- Myrbetriq (Drug) $27.16
- Rybelsus (Drug) $26.52
- Ozempic (Drug) $25.18
- Tresiba (Drug) $23.93
- Kerendia (Drug) $18.49
- PRADAXA (Drug) $16.36
- GARDASIL (Biological) $15.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.